ArticleContemporary clinical trials communications2021

Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain - Study protocol for a randomized double-blind controlled study.

H M Schenker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.